-
The challenges posed by the Covid-19 pandemic have stimulated innovation on several fronts. One is the development of low-cost methods of clinical diagnosis. A device of this kind has just been produced in Brazil by a multidisciplinary team of researchers affiliated with various institutions.
Leader of the team is the physicist Osvaldo Novais de Oliveira Junior, a professor at the University of São Paulo's São Carlos Institute of Physics (IFSC-USP).
The result of the [...]
-
An impedance analyzer connected to DNA biosensor can be used to detect genetic sequence from SARS-CoV-2.
A multidisciplinary team of researchers affiliated with various institutions and led by the University of São Paulo’s São Carlos Institute of Physics (IFSC-USP; São Paulo, Brazil) has developed the device which has already shown to be efficient in detecting SARS-CoV-2. The result of the analysis can be ready in 30 minutes, for a laboratory-scale cost of less than [...]
-
The challenges posed by the COVID-19 pandemic have stimulated innovation on several fronts. One is the development of low-cost methods of clinical diagnosis. Genosensors are a case in point. Based on nucleic acids that detect simple complementary DNA or RNA sequences, genosensors are biosensors that make possible mass testing for immediate and sensitive testing of genetic material.
A device of this kind, already shown to be efficient in detecting SARS-CoV-2, has just been produced in Brazil by [...]
-
The challenges posed by the COVID-19 pandemic have stimulated innovation on several fronts. One is the development of low-cost methods of clinical diagnosis. Genosensors are a case in point. Based on nucleic acids that detect simple complementary DNA or RNA sequences, genosensors are biosensors that make possible mass testing for immediate and sensitive testing of genetic material.
A device of this kind, already shown to be efficient in detecting SARS-CoV-2, has just been produced in Brazil by [...]
-
Diagnosis can be made in 30 minutes, for a laboratory-scale cost of less than 1 US Dollar per genosensor. The components cost less than USD 200. The device exists at the laboratory scale, and the technology can be transferred to any company with the wherewithal to mass-produce it.
“Our genosensor can immobilize a simple DNA strip used as a capture probe. Under appropriate conditions, the immobilized strip binds to a complementary DNA strip contained in the liquid sample to be [...]
-
Genosensors are inexpensive biosensors that help in rapid diagnosis of viruses. Based on nucleic acids that detect simple complementary DNA or RNA sequences, genosensors make possible mass testing for immediate and sensitive testing of genetic material.
This device is produced in Brazil by various researchers and led by physicist Osvaldo Novais de Oliveira Junior, a professor at the University of São Paulo's São Carlos Institute of Physics (IFSC-USP).
Diagnosis can be made [...]
-
The challenges posed by the COVID-19 pandemic have stimulated innovation on several fronts. One is the development of low-cost methods of clinical diagnosis. Genosensors are a case in point. Based on nucleic acids that detect simple complementary DNA or RNA sequences, genosensors are biosensors that make possible mass testing for immediate and sensitive testing of genetic material.
A device of this kind, already shown to be efficient in detecting SARS-CoV-2, has just been produced in Brazil by [...]
-
Impedance analyzer connected to DNA biosensor that can be used to detect genetic sequence from SARS-CoV-2.
The challenges posed by the COVID-19 pandemic have stimulated innovation on several fronts. One is the development of low-cost methods of clinical diagnosis. Genosensors are a case in point. Based on nucleic acids that detect simple complementary DNA or RNA sequences, genosensors are biosensors that make possible mass testing for immediate and sensitive testing of genetic material.
A [...]
-
The challenges posed by the COVID-19 pandemic have stimulated innovation on a number of fronts. One is the event of low-cost strategies of medical prognosis. Genosensors are a living proof. Based on nucleic acids that detect easy complementary DNA or RNA sequences, genosensors are biosensors that make potential mass testing for rapid and delicate testing of genetic materials.
A tool of this sort, already proven to be environment friendly in detecting SARS-CoV-2, has simply been produced in [...]
-
BKBC
- Publicado em 11 agosto 2021
The challenges posed by the COVID-19 pandemic have stimulated innovation on several fronts. One is the development of low-cost methods of clinical diagnosis. Genosensors are a case in point. Based on nucleic acids that detect simple complementary DNA or RNA sequences, genosensors are biosensors that make possible mass testing for immediate and sensitive testing of genetic material.
A device of this kind, already shown to be efficient in detecting SARS-CoV-2, has just been produced in Brazil by [...]
